Literature DB >> 32890264

Genetics, prevalence, screening and confirmation of primary aldosteronism: a position statement and consensus of the Working Group on Endocrine Hypertension of The European Society of Hypertension.

Paolo Mulatero1, Silvia Monticone1, Jaap Deinum2,3, Laurence Amar4, Aleksander Prejbisz5, Maria-Christina Zennaro6,7, Felix Beuschlein8,9, Gian Paolo Rossi10, Tetsuo Nishikawa11, Alberto Morganti12, Teresa Maria Seccia10, Yen-Hung Lin13, Francesco Fallo14, Jiri Widimsky15.   

Abstract

: Autonomous aldosterone overproduction represents the underlying condition of 5-10% of patients with arterial hypertension and carries a significant burden of mortality and morbidity. The diagnostic algorithm for primary aldosteronism is sequentially based on hormonal tests (screening and confirmation tests), followed by lateralization studies (adrenal CT scanning and adrenal venous sampling) to distinguish between unilateral and bilateral disease. Despite the recommendations of the Endocrine Society guideline, primary aldosteronism is largely underdiagnosed and undertreated with high between-centre heterogeneity. Experts from the European Society of Hypertension have critically reviewed the available literature and prepared a consensus document constituting two articles to summarize current knowledge on the epidemiology, diagnosis, treatment, and complications of primary aldosteronism.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32890264     DOI: 10.1097/HJH.0000000000002510

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  31 in total

1.  Aldosterone-producing adenoma associated with non-suppressed renin: a case series.

Authors:  Pieter Martijn Jansen; Michael Stowasser
Journal:  J Hum Hypertens       Date:  2021-03-30       Impact factor: 3.012

2.  Curable congestive heart failure in patients with primary aldosteronism: two cases reports.

Authors:  Zijun Chen; Zhe Zhang; Qianlan Xi; Guimei Huang; Liya Wang
Journal:  Am J Transl Res       Date:  2022-04-15       Impact factor: 4.060

Review 3.  High Prevalence of Autonomous Aldosterone Production in Hypertension: How to Identify and Treat It.

Authors:  Taweesak Wannachalee; Leedor Lieberman; Adina F Turcu
Journal:  Curr Hypertens Rep       Date:  2022-02-14       Impact factor: 5.369

4.  False-negative aldosterone-to-renin ratio in a primary aldosteronism patient complicated with primary polydipsia: case report.

Authors:  Chengcheng Zheng; Lianling Zhao; Chang Zheng; Yan Ren; Haoming Tian; Tao Chen
Journal:  Gland Surg       Date:  2022-01

5.  Adrenal venous sampling in primary aldosteronism: Experience of a Spanish multicentric study (Results from the SPAIN-ALDO Register).

Authors:  Marta Araujo-Castro; Miguel Paja Fano; Marga González Boillos; Begoña Pla Peris; Eider Pascual-Corrales; Ana María García Cano; Paola Parra Ramírez; Patricia Martín Rojas-Marcos; Jorge Gabriel Ruiz-Sanchez; Almudena Vicente Delgado; Emilia Gómez Hoyos; Rui Ferreira; Iñigo García Sanz; Mònica Recasens Sala; Rebeca Barahona San Millan; María José Picón César; Patricia Díaz Guardiola; Juan Jesús García González; Carolina M Perdomo; Laura Manjón Miguélez; Rogelio García Centeno; Juan Carlos Percovich; Ángel Rebollo Román; Paola Gracia Gimeno; Cristina Robles Lázaro; Manuel Morales-Ruiz; Felicia A Hanzu
Journal:  Endocrine       Date:  2022-06-25       Impact factor: 3.925

6.  2022 Guidelines of the Taiwan Society of Cardiology and the Taiwan Hypertension Society for the Management of Hypertension.

Authors:  Tzung-Dau Wang; Chern-En Chiang; Ting-Hsing Chao; Hao-Min Cheng; Yen-Wen Wu; Yih-Jer Wu; Yen-Hung Lin; Michael Yu-Chih Chen; Kwo-Chang Ueng; Wei-Ting Chang; Ying-Hsiang Lee; Yu-Chen Wang; Pao-Hsien Chu; Tzu-Fan Chao; Hsien-Li Kao; Charles Jia-Yin Hou; Tsung-Hsien Lin
Journal:  Acta Cardiol Sin       Date:  2022-05       Impact factor: 1.800

Review 7.  Primary aldosteronism in pregnancy.

Authors:  Vittorio Forestiero; Elisa Sconfienza; Paolo Mulatero; Silvia Monticone
Journal:  Rev Endocr Metab Disord       Date:  2022-05-10       Impact factor: 9.306

8.  Risk Factors Associated With Lower Bone Mineral Density in Primary Aldosteronism Patients.

Authors:  Xiaomei Lv; Huijun Hu; Chuyu Shen; Xiaoyun Zhang; Li Yan; Shaoling Zhang; Ying Guo
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-16       Impact factor: 6.055

9.  Assessment of Anti-Hypertensive Drug Adherence by Serial Aldosterone-To-Renin Ratio Measurement.

Authors:  Fabrizio Buffolo; Elisa Sconfienza; Jacopo Burrello; Isabel Losano; Giulio Mengozzi; Gabriella Priolo; Valeria Avataneo; Antonio D'Avolio; Franco Veglio; Franco Rabbia; Paolo Mulatero; Silvia Monticone
Journal:  Front Pharmacol       Date:  2021-05-10       Impact factor: 5.810

10.  A case of primary aldosteronism with a negative aldosterone-to-renin ratio.

Authors:  Fengyi Liu; Liang Wang; Yanchun Ding
Journal:  BMC Cardiovasc Disord       Date:  2021-07-22       Impact factor: 2.298

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.